Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice

Molecular Nutrition and Food Research

Volumn 53, Issue 7, 2009, Pages 859-868

  Kobori, Msauko ^a   Masumoto, Saeko ^a   Akimoto, Yukari ^a   Takahashi, Yumiko ^a  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

Cdkn1a; Diabetes; Mouse liver; Quercetin; Streptozotocin

Indexed keywords

CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; INSULIN; QUERCETIN; STREPTOZOCIN; UBIQUITIN C;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION PROFILING; GENETICS; GLUCOSE BLOOD LEVEL; LIVER; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; PANCREAS;

ANIMALS; BLOOD GLUCOSE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION PROFILING; INSULIN; LIVER; MALE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; PANCREAS; QUERCETIN; STREPTOZOCIN; UBIQUITIN C;

MUS;

EID: 67149116251     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800310     Document Type: Article

References (36)

1. Rao, Y. K., Geethangili, M., Fang, S. H., Tzeng, Y. M., Antioxidant and cytotoxic activities of naturally occurring phenolic and related compounds: A comparative study, Food Chem. Toxicol. 2007, 45, 1770-1776.
2. Dufour, C., Loonis, M., Flavonoids and their oxidation products protect efficiently albumin-bound linoleic acid in a model of plasma oxidation, Biochim. Biophys. Acta 2007, 1770,958-965.
3. Dias, A. S., Porawski, M., Alonso, M., Marroni, N., et al., Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats, J. Nutr. 2005, 135, 2299-2304.
4. Mahesh, T., Menon, V. P., Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats, Phytother. Res. 2004, 18,123-127.
5. Russo, G. L., Ins and outs of dietary phytochemicals in cancer chemoprevention, Biochem. Pharmacol. 2007, 74, 533-544.
6. Arts, I. C., Hollman, P. C., Polyphenols and disease risk in epidemiologic studies, Am. J. Clin. Nutr. 2005, 81, 317S-325S.
7. Skibola, C. F., Smith, M. T., Potential health impacts of excessive flavonoid intake, Free Radic. Biol. Med. 2000, 29, 375-383.
8. Conseil, G., Baubichon-Cortay, H., Dayan, G., Jault, J., et al., Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein, Proc. Natl. Acad. Sci. USA 1998, 95, 9831-9836.
9. Hosokawa, N., Hirayoshi, K., Kudo, H., Takechi, H., et al., Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids, Mol. Cell. Biol. 1992, 12, 3490-3498.
10. van Meeuwen, J. A., Korthagen, N., de Jong, P. C., Piersma, A. H., van den Berg, M., (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture, Toxicol. Appl. Pharmacol. 2007, 221,372-383.
11. Coskun, O., Kanter, M., Korkmaz, A., Oter, S., Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas, Pharmacol. Res. 2005, 51, 117-123.
12. Anjaneyulu, M., Chopra, K., Quercetin, an anti-oxidant bio-flavonoid, attenuates diabetic nephropathy in rats, Clin. Exp. Pharmacol. Physiol. 2004, 31, 244-248.
13. de Boer, V. C., Dihal, A. A., van der Woude, H., Arts, I. C., et al., Tissue distribution of quercetin in rats and pigs, J. Nutr. 2005,135,1718-1725.
14. Cao, Z., Li, Y., The chemical inducibility of mouse cardiac antioxidants and phase 2 enzymes in vivo, Biochem. Biophys. Res. Commun. 2004, 317, 1080-1088.
15. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA 2005, 102, 15545-15550.
16. Mootha, V. K., Lindgren, C. M., Eriksson, K. F., Subramanian, A. et al., PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet. 2003, 34, 267-273.
17. Smyth, G. K., Linear models and empirical Bayes methods for assessing differential expression in microarray experiments, Stat. Appl. Genet. Mol. Biol. 2004, 3, Article 3.
18. Smyth, G. K., Bioinformatics and Computational Biology Solutions using R and Bioconductor, Springer, New York 2005, pp. 397-420.
19. Kwon, Y. H., Jovanovic, A., Serfas, M. S., Tyner, A. L., The Cdk inhibitor p21 is required for necrosis, but it inhibits apoptosis following toxin-induced liver injury, J. Biol. Chem. 2003,278,30348-30355.
20. Sanders, R. A., Rauscher, F. M., Watkins, J. B., III, Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 2001, 15, 143-149.
21. Day, A. J., Mellon, F., Barron, D., Sarrazin, G., et al., Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin, Free. Radic. Res. 2001, 35, 941-952.
22. Graf, B. A., Ameho, C., Dolnikowski, G. G., Milbury, P. E., et al., Rat gastrointestinal tissues metabolize quercetin, J. Nutr. 2006,136,39-44.
23. McAnlis, G. T., McEneny, J., Pearce, J., Young, I. S., Absorption and antioxidant effects of quercetin from onions, in man, Eur. J. Clin. Nutr. 1999, 53, 92-96.
24. Elsner, M., Guldbakke, B., Tiedge, M., Munday, R., Lenzen, S., Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin, Diabetologia 2000,43,1528-1533.
25. Kume, E., Fujimura, H., Matsuki, N., Ito, M., et al., Hepatic changes in the acute phase of streptozotocin (SZ)-induced diabetes in mice, Exp. Toxicol. Pathol. 2004, 55, 467-480.
26. Kume, E., Aruga, C., Ishizuka, Y., Takahashi, K., et al., Gene expression profiling in streptozotocin treated mouse liver using DNA microarray, Exp. Toxicol. Pathol. 2005, 56, 235-244.
27. Dhahbi, J. M., Mote, P. L., Cao, S. X., Spindler, S. R., Hepatic gene expression profiling of streptozotocin-induced diabetes, Diabetes Technol. Ther. 2003, 5, 411-420.
28. Susztak, K., Bottinger, E., Novetsky, A., Liang, D., et al., Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease, Diabetes 2004, 53, 784-794.
29. Crary, G. S., Albrecht, J. H., Expression of cyclin-dependent kinase inhibitor p21 in human liver, Hepatology 1998, 28, 738-743.
30. Waf-1/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis, Hepatology 2005, 41, 1262-1271.
31. Albrecht, J. H., Poon, R. Y. C., Ahonen, C. L., Rieland, B. M. et al., Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver, Oncogene 1998, 16, 2141-2150.
32. Waf1/Cip1 and the prevention of oxidative stress, Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 286, L502-L505.
33. Georgia, S., Bhushan, A., p27 regulates the transition of betacells from quiescence to proliferation, Diabetes 2006, 55, 2950-2956.
34. Janssen, K., Mensink, R. P., Cox, F. J., Harryvan, J. L., et al., Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study, Am. J. Clin. Nutr. 1998, 67, 255-262.
35. Ryu, K. Y., Maehr, R., Gilchrist, C. A., Long, M. A., et al., The mouse polyubiquitin gene UbC is essential for fetal liver development, cell-cycle progression and stress tolerance, EMBO J. 2007, 26, 2693-2706.
36. Sonna, L. A., Wenger, C. B., Flinn, S., Sheldon, H. K., et al., Exertional heat injury and gene expression changes: A DNA microarray analysis study, J. Appl. Physiol. 2004, 96, 1943-1953.